Financial News
Poolbeg Pharma "really open" to different types of deal for POLB 001
March 01, 2023 at 03:40 AM EST
Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) VP of Business Development David English speaks to Proactive's Thomas Warner about the work he's doing to progress the clinical stage infectious disease pharmaceutical company's lead asset POLB 001.
English says that Poolbeg is "in a good position" for partnering in general, adding that the company is "really open" to different types of deals for lead asset POLB 001.
Contact Details
Proactive UK Ltd
+44 20 7989 0813
More News
View More
Post 35% Surge, Analysts Eye More Upside in Copper Giant Freeport ↗
December 17, 2025
Why a SpaceX IPO Could Be a Major Catalyst for GOOGL Stock ↗
December 17, 2025
Can Upwork Maintain Its Comeback? Reasons to Be Bullish and Bearish ↗
December 17, 2025
Is Tesla Overvalued? 2 Reasons It Might Be a Bargain ↗
December 17, 2025
Recent Quotes
View More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
